Morepen Board proposed dividend after 23 years
Scores highest PAT of Rs. 118 crore in FY25
Scores highest PAT of Rs. 118 crore in FY25
The Q1 2025 also witnessed a successful launch of Allegra D
The company is targeting a Rs. 1,000 crore finished dosages business within the next five years
Introduces revolutionary approach to workflow management to enhance operational efficiency and optimize process efficiency
The acquisition of MDxK further strengthens the Business Unit’s position in the molecular diagnostics market
Alembic Pharmaceuticals Ltd. and Amlan International sign exclusive strategic commercial agreement to make poultry health innovations accessible to Indian farmers and integrators
Empagliflozin and its Fixed Drug Combinations (FDCs) have been launched under the brand names Glempa, Glempa –L and Glempa-M
Amplitude Surgical is a European MedTech leader in high-quality, lower-limb orthopaedic technologies
Metropolis Clinical Pathology will acquire and operate all laboratories and collection centers of Scientific Pathology in Agra and neighbouring towns through a slump sale transaction
 
        Subscribe To Our Newsletter & Stay Updated